EP Patent

EP2415041B1 — Method for manufacturing a drug delivery device body using an adhesive and drug delivery device body

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2018-11-21 · 7y expired

What this patent protects

Patent listed against testosterone-enanthate.

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: EP2415041B1
Jurisdiction: EP
Classification: —
Expires: 2018-11-21
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi Aventis Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.